Chronic Kidney Disease Study

Living with Chronic Kidney Disease (CKD) is more than just managing a medical condition—it’s a journey that can affect nearly every aspect of life, from physical health to emotional well-being and daily routines. For many, CKD brings challenges that are not always visible to others but are deeply felt every day.

CKD is a condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This can lead to serious health problems, including heart disease and kidney failure.

Although current therapies are beneficial, they do not always prevent the progression of kidney disease, and they cannot address all the complications CKD presents.

This clinical research study aims to slow the progression of CKD, improve quality of life, and reduce the need for invasive treatments like dialysis.

We are conducting a clinical research study to evaluate whether starting two currently available medications—vicadrostat and empagliflozin—at the same time is as safe and effective as introducing them one at a time. These medications help protect the kidneys and manage blood pressure in people with Chronic Kidney Disease (CKD). It is hoped that this new approach could improve kidney function and delay disease progression.

During the study, participants will receive ongoing health monitoring and assessments with our professional medical team. 

Register your interest now to find out if you are eligible to participate in this study and help develop a potential new treatment approach for people living with chronic kidney disease.